MN Services Vermogensbeheer’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.6M Sell
2,194,011
-2,600
-0.1% -$69.2K 0.41% 49
2025
Q4
$54.7M Buy
2,196,611
+37,611
+2% +$948K 0.34% 63
2025
Q3
$55M Buy
2,159,000
+38,800
+2% +$958K 0.36% 61
2025
Q2
$51.4M Buy
2,120,200
+51,900
+3% +$1.21M 0.36% 60
2025
Q1
$52.4M Sell
2,068,300
-162,000
-7% -$4.24M 0.41% 52
2024
Q4
$59.2M Buy
2,230,300
+46,200
+2% +$1.25M 0.4% 50
2024
Q3
$63.2M Sell
2,184,100
-47,800
-2% -$1.39M 0.44% 48
2024
Q2
$62.4M Sell
2,231,900
-50,900
-2% -$1.4M 0.45% 44
2024
Q1
$63.3M Sell
2,282,800
-385,500
-14% -$10.7M 0.46% 45
2023
Q4
$76.8M Sell
2,668,300
-85,800
-3% -$2.59M 0.69% 33
2023
Q3
$91.4M Buy
2,754,100
+57,400
+2% +$2.03M 0.88% 24
2023
Q2
$98.9M Buy
+2,696,700
New +$105M 0.92% 22
2019
Q3
Sell
-1,002,761
Closed -$41.2M 542
2019
Q2
$41.2M Sell
1,002,761
-44,900
-4% -$1.78M 0.48% 45
2019
Q1
$42.2M Sell
1,047,661
-4,849
-0.5% -$194K 0.49% 49
2018
Q4
$38.1M Buy
1,052,510
+63,240
+6% +$2.63M 0.58% 42
2018
Q3
$41.4M Sell
989,270
-8,748
-0.9% -$337K 0.97% 13
2018
Q2
$34.4M Buy
998,018
+9,908
+1% +$339K 0.86% 19
2018
Q1
$33.3M Buy
988,110
+9,486
+1% +$326K 0.87% 18
2017
Q4
$28M Sell
978,624
-58,708
-6% -$2M 0.88% 19
2017
Q3
$35.1M Buy
1,037,332
+12,715
+1% +$409K 0.92% 16
2017
Q2
$32.7M Buy
1,024,617
+853,670
+499% +$26.9M 0.9% 16
2017
Q1
$5.19M Buy
170,947
+4,740
+3% +$149K 1% 15
2016
Q4
$4.86M Buy
166,207
+837
+0.5% +$25.6K 0.99% 18
2016
Q3
$5.31M Buy
165,370
+218
+0.1% +$7.29K 1.06% 15
2016
Q2
$4.97M Buy
165,152
+2,057
+1% +$65.7K 1.15% 13
2016
Q1
$4.03M Buy
+163,095
New +$4.66M 0.94% 16

Other funds holding PFE

MN Services Vermogensbeheer's PFE Position: Q1 2026 in Review

MN Services Vermogensbeheer reduced its Pfizer (PFE) stake by 0.12% in Q1 2026, selling an estimated $69.2K and leaving 2,194,011 shares worth $61.6M. The position accounts for 0.41% of the portfolio, ranked #49.

MN Services Vermogensbeheer first reported a position in PFE in Q1 2016 and has held it in 26 quarters since. The position peaked at $98.9M in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MN Services Vermogensbeheer held 2,194,011 shares of Pfizer worth $61.6M as of Q1 2026.
  • MN Services Vermogensbeheer sold 2,600 Pfizer shares in Q1 2026, an estimated $69.2K.
  • Pfizer made up 0.41% of MN Services Vermogensbeheer's portfolio in Q1 2026, its #49 holding.
  • MN Services Vermogensbeheer first reported a position in Pfizer in Q1 2016 and has held it in 26 quarters since.
  • MN Services Vermogensbeheer's Pfizer position peaked at $98.9M in Q2 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.